Monopolar electrosurgery instrument market to hit $2.92B by 2030

The global monopolar electrosurgery instrument market is projected to grow from $2.41 billion in 2026 to $2.92 billion by 2030, driven by rising surgery volumes, healthcare spending and demand for minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Monopolar electrosurgery instruments are core tools in surgery because they cut tissue and control bleeding with high-frequency electrical current. - The market’s projected growth signals sustained demand for devices that can support precise procedures, reduce blood loss and shorten hospital stays. - The shift toward minimally invasive surgery and outpatient care could continue to favor portable and programmable electrosurgery systems.

What happened: - The Business Research Company released its Monopolar Electrosurgery Instrument Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Aug. 19, 2026. - The report says the market will rise from $2.29 billion in 2025 to $2.41 billion in 2026, a 5.2% increase. - The market is projected to reach $2.92 billion by 2030, growing at a 4.9% CAGR during the forecast period. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample and the full report are available through the company’s website: Download a free sample and View the full market report.

The details: - Monopolar electrosurgery instruments use an active electrode to send current through the patient’s body to a return electrode, usually a grounding pad, to complete the circuit. - The instruments are used across general surgery, gynecology and urology. - The report links recent market growth to widespread use of open surgeries, higher hospital infrastructure investment, broader acceptance of radiofrequency electrosurgery, rising chronic disease rates and the cost-effectiveness of monopolar systems. - Expected growth drivers include more minimally invasive procedures, improvements in energy delivery systems, more surgeries among aging populations and growth in ambulatory surgical centers. - The report also points to rising demand for portable and programmable electrosurgery generators. - Anticipated developments include greater use of minimally invasive techniques, tighter focus on precision and reduced thermal damage, more outpatient procedures and standardized safety protocols. - The British Association of Aesthetic Plastic Surgeons reported 27,462 cosmetic surgeries in the UK in 2024, up 5% from 2023. - UK total healthcare expenditure rose 6.5% in nominal terms and 2.4% after inflation between 2023 and 2024, according to the Office for National Statistics.

Between the lines: - The report’s growth story is tied less to one procedure type and more to a wider surgical mix that includes open, minimally invasive and outpatient settings. - Rising healthcare spending and more surgery volume suggest hospitals and ambulatory centers may keep investing in tools that improve efficiency and control complications. - The regional split suggests the market is mature in North America but still has more runway in Asia-Pacific.

What's next: - The market’s next phase will likely be shaped by adoption of safer, more precise energy delivery systems. - More outpatient and ambulatory procedures could expand demand for flexible electrosurgery equipment. - The Business Research Company said its 2026 reports also include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - Monopolar electrosurgery instruments are on track for steady global growth as surgery volumes rise and healthcare systems push for more efficient, less invasive procedures.